Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Neuroprotective Effects of Dexmedetomidine on Cerebral Ischemia-Reperfusion Injury and Postoperative Delirium Biomarkers in Endovascular Stroke Intervention
ChiCTR2500110474Phase 4Not yet recruiting
- Sponsor
- The First Hospital of Hebei Medical University
- Start
- Oct 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in ischemic stroke and postoperative delirium (POD) comparing Dexmedetomidine group with Placebo control group (2 arms). Primary endpoint: Incidence of postoperative delirium. Planned start Oct 2025; status: not yet recruiting.
02
Drugs
dexmedetomidine
03
Conditions
ischemic strokepostoperative delirium (POD)
Beyond the preview
Go deeper on ChiCTR2500110474.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500110474.